Abstract
The phase I study of the Protocol approved by State Institute for Drug Control and State Office for Nuclear Safety of the Czech Republic has been used to define the limiting toxicity of the BNCT procedure. The group of nine patients received BSH and underwent surgery, five patients with glioblastoma multiforme were treated using BSH and the epithermal neutron facility of LVR-15 reactor in NRI Rez.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
